Shufen Li

3.1k citations
98 papers · 1.8k indexed · 1 hit paper · h-index 20
Topics
Microbial Natural Products and Biosynthesis (16 papers)Viral Infections and Vectors (9 papers)interferon and immune responses (5 papers)
Partner nations
ChinaTaiwanFrance

In The Last Decade

Shufen Li

93 papers receiving 1.7k citations

Hit Papers

Calcium channel blocker amlodipine besylate therapy is as...2020202620222024202050100150200

Peers

Shufen Li
Comparison fields: 5 of 138
  • Molecular Biology 614
  • Infectious Diseases 491
  • Immunology 294
  • Epidemiology 189
  • Pharmacology 149
Replace Yanxia Liu with:
Yanxia Liu China
Yanping Wang China
Mohsen Nabi‐Afjadi Iran
Prashant Chauhan India
Haifeng Zhou China
Noriko Iwamoto Japan
Lingli Dong China
Jing Gong China
Mohamed Abu‐Farha Kuwait
Nikolaos Drakoulis Greece
Shufen Li relative to Yanxia Liu China Yanxia Liu's profile →
Citations per field
00.5×1.5×
Yanxia Liu · 1×
Citations per year

Countries citing papers authored by Shufen Li

Since Specialization
Citations

This map shows the geographic impact of Shufen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufen Li more than expected).

Fields of papers citing papers by Shufen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufen Li. The network helps show where Shufen Li may publish in the future.

Co-authorship network of co-authors of Shufen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shufen Li. A scholar is included among the top collaborators of Shufen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufen Li. Shufen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 9
4 1
5 0
6 9
7 7
8 0
9 8
10 3
11 254
12 112
13 6
14 44
15 7
16
[Identification of 3-demethylchuangxinmycin from Actinoplanes tsinanensis CPCC 200056].
3
17 23
18
Identification of quinomycins as principal secondary metabolites from Streptomyces sp. CPCC 200497
2
19
RP-HPLC determination of four compounds of flavonoids in Houttuynia cordata Thunb.
1
20
A comparative study of loxapine and risperidone in the treatment of schizophrenic patients
2

About Shufen Li

Shufen Li is a scholar working on Pharmacology, Toxicology and Infectious Diseases, having authored 98 papers that have together received 1.8k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (16 papers), Viral Infections and Vectors (9 papers) and interferon and immune responses (5 papers). The work is most often cited by research in Infectious Diseases (491 citations), Immunology (294 citations) and Cancer Research (149 citations). Shufen Li has collaborated with scholars based in China, Taiwan and France. Frequent co-authors include Ke Peng, Zhenqiong Guan, Yulan Zhang, Xi Chen, Huiling Li, Peng Zhou, Wei Liu, Leike Zhang, Gengfu Xiao and Ying Zhang. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026